Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

NANot yet recruitingINTERVENTIONAL
Enrollment

2,353

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Venous ThromboembolismDigital HealthHealth Education
Interventions
DEVICE

mobile venous thromboembolism application (mVTEA)

mVTEA will assist in the management of patients with high-risk of VTE during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends VTE-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.

Trial Locations (1)

100048

Sixth Medical Center of Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Navy General Hospital, Beijing

OTHER

NCT06350344 - Smart Technology Facilitated Patient-centered Venous Thromboembolism Management | Biotech Hunter | Biotech Hunter